CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Clearmind Medicine Inc.
Financials through Q3 FY2026, quarter ended Jul 31, 2026
$6.00−0.26 (-4.15%)
Close on Oct 19, 2026
- Market cap
- $9.49M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Oct 5, 2026 | 1-for-8 reverse | Earlier per-share figures multiplied by 8 |
| May 21, 2026 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Jan 20, 2026(first seen in filings) | 1-for-40 reverse | Earlier per-share figures multiplied by 40 |
| Dec 15, 2025 | 1-for-40 reverse | Earlier per-share figures multiplied by 40 |
| Jan 29, 2024(first seen in filings) | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |
| Nov 28, 2023 | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |